NCT06254495
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06254495
Title A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seagen, a wholly owned subsidiary of Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | DNK | DEU


No variant requirements are available.